Insmed Incorporated (INSM) was a big mover last session, as its shares rose nearly 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend for the company, as the stock is now down almost 31% in the past one-month timeframe.
In the last 30 days, the company witnessed two negative estimate revisions and the Zacks Consensus Estimate also moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move higher lasts.
Insmed Incorporated currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
Other better-ranked stocks in the biomedical/gene industry include Actelion Ltd. (ALIOF), Cambrex Corporation. (CBM) and China Biologic Products, Inc. (CBPO). All three sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>
CHINA BIOLOGIC PRODUCTS INC (CBPO): Free Stock Analysis Report
CAMBREX CORP (CBM): Free Stock Analysis Report
ACTELION LTD (ALIOF): Free Stock Analysis Report
INSMED INC (INSM): Free Stock Analysis Report
Zacks Investment Research